Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. N271813PEC5

AK5 Antibody (OTI2F9), PE/Cy5.5, Novus Biologicals™
SDP

Catalog No. N271813PEC5 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
N271813PEC5 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. N271813PEC5 Supplier Novus Biologicals Supplier No. NBP271813PECY55
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

AK5 Monoclonal specifically detects AK5 in Human, Mouse, Rat samples. It is validated for Flow Cytometry.

Specifications

Antigen AK5
Applications Flow Cytometry
Classification Monoclonal
Clone OTI2F9
Conjugate PE-Cyanine5.5
Dilution Flow Cytometry
Formulation PBS with 0.05% Sodium Azide
Gene Alias adenylate kinase 5, adenylate kinase 6, adenylate kinase isoenzyme 5, AK 5, AK6, ATP-AMP transphosphorylase 5, EC 2.7.4.3, MGC33326
Gene Symbols AK5
Host Species Mouse
Immunogen Full length recombinant protein of human AK5 (NP_777283) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Research Discipline metabolism
Primary or Secondary Primary
Gene ID (Entrez) 26289.0
Target Species Human, Mouse, Rat
Content And Storage Store at 4°C in the dark. Do not freeze.
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.